Last reviewed · How we verify
NCT03816670
Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF
NA trial testing Corifollitropin Alfa in Fertility Disorders in 113 participants. Completed in 31 December 2018.
30 April 2018
Quick facts
| Lead sponsor | University of Turin, Italy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 113 |
| Start date | 1 April 2017 |
| Primary completion | 30 April 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Corifollitropin Alfa (CORIFOLLITROPIN ALFA) — full drug profile →
Conditions studied
- Fertility Disorders — all drugs for Fertility Disorders →
Sponsor
University of Turin, Italy
Who can join
Adults 18 to 43, female only, with Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the number of retrieved oocytes in the late start CF-alfa (day 4) versus standard CF-alfa protocols (day 2) in patients undergoing IVF. The primary analysis will be also performed in specific subgroups of patients: expected poor-responders, expected normal responders and expected hyper-responders
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF.
Revelli A, Gennarelli G, Sestero M, Canosa S, et al · · 2020 · cited 12× · PMID 32185595 · DOI 10.1007/s10815-020-01742-5
Verify or expand the search:
- PubMed search for NCT03816670
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Corifollitropin Alfa
Trials testing the same drug.
- NCT05815719 — Continuous Double Ovarian Stimulation. · Phase 4 · completed
- NCT04416607 — Corifollitropin Alpha and Ovarian Response · NA · completed
- NCT03197077 — Optimisation of Follicular Recruitment in IVM Cycles · Phase 3 · completed
Other recruiting trials for Fertility Disorders
Currently open trials in the same condition.
- NCT07017972 — Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model · recruiting
- NCT06928337 — Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. · recruiting
- NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
- NCT04663971 — Fertility and Pregnancy After Surgery IBD Audit · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
Other University of Turin, Italy trials
Trials by the same sponsor.
- NCT06493188 — Low VS High-fidelity Interprofessional Simulation for ABG Skills Acquisition · NA · not yet recruiting
- NCT07418489 — Biotics Intervention Oriented to Rescue From Environmental Pollution Inflammatory Responses · NA · enrolling by invitation
- NCT07311291 — The Effect of Different Hemostatic Agents on Hemorrhage Control, Pain and Quality of Life After Endodontic Microsurgery. · NA · completed
- NCT06904963 — Efficacy of Oral Hygiene Instructions Carried Out Using an Intra-oral Scanner · NA · completed
- NCT07047261 — Efficacy of a Xanthan-based Chlorhexidine Gel in the Treatment of Peri-implant Mucositis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03816670 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Turin, Italy
- Last refreshed: 25 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03816670.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing